The Rapid Emergence of Ceftazidime-Avibactam Resistance Mediated by KPC Variants in Carbapenem-Resistant <i>Klebsiella pneumoniae</i> in Zhejiang Province, China

Ceftazidime-avibactam (CAV) is a new treatment option against carbapenem-resistant <i>Klebsiella pneumoniae</i> (CRKP) infections. However, the rapid emergence of CAV resistance mediated by KPC variants has posed a severe threat to healthcare after its clinical application. The character...

Full description

Bibliographic Details
Main Authors: Congcong Liu, Yuchen Wu, Ling Huang, Yanyan Zhang, Qiaoling Sun, Jiayue Lu, Yu Zeng, Ning Dong, Chang Cai, Zhangqi Shen, Gongxiang Chen, Rong Zhang
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/11/6/731